CARDOZA GEORGE 4
4 · SOPHiA GENETICS SA · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CFO George Cardoza Sells 774 Shares
What Happened George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA (SOPH), sold 774 shares on June 22, 2026, for total proceeds of approximately $4,164. The reported weighted-average sale price was $5.38 per share (individual trades ranged $5.33–$5.46). This was a sale to satisfy tax withholding tied to restricted stock units that vested on June 18, 2026, and is generally considered a routine, non-discretionary transaction.
Key Details
- Transaction date: 2026-06-22 (reported on Form 4 filed 2026-06-23). Filing appears timely.
- Amount sold: 774 shares; weighted-average price: $5.38; total proceeds ≈ $4,164.
- Price range: $5.33 to $5.46 across multiple trades (report lists weighted average; reporting person will provide breakdown on request).
- Purpose/footnote: Sale effected pursuant to a pre-established Rule 10b5-1(c) trading plan to satisfy tax withholding obligations from RSU vesting on 2026-06-18 (not a discretionary sell).
- Shares owned after the transaction: not disclosed in the filing.
Context This was a tax-withholding sale related to RSU vesting and executed under a 10b5-1 plan—common for executives and typically not read as a signal of company outlook. Purchases by insiders tend to carry more weight for bullish signals; routine withholding sales are administrative.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-06-22$5.38/sh−774$4,164→ 310,684 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on June 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.33 to $5.46, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.